Stay updated on Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.

Latest updates to the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new Study Status entry on 2026-01-02 and a new version 68 on 2025-12-30. The 2025-07-18 entry was deleted.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new entry Revision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.1%

- Check47 days agoChange DetectedThe change log shows a minor version bump from v3.3.1 to v3.3.2 in the page's revision history, with no impact on visible study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, indicating a system update to the site's history view. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe government funding notice at the top of the page has been removed. Previously the page displayed a banner about updates and operating status.SummaryDifference0.3%

- Check76 days agoChange DetectedA new version entry was added to the record history, reflecting an update to the study's status in the latest submission. The rest of the page content and structure remains unchanged.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.